Guangdong Hybribio Biotech Company Overview

  • Year Founded
  • 2003

Year Founded

  • Status
  • Public

  • Employees
  • 1,990

Employees

  • Stock Symbol
  • 300639

Stock Symbol

  • Investments
  • 7

  • Share Price
  • $0.82
  • (As of Friday Closing)

Guangdong Hybribio Biotech Company General Information

Description

Guangdong Hybribio Biotech Co Ltd is engaged in the Research, development, production, and sales of in vitro diagnostic products such as molecular diagnostic reagents and related instruments, and provision of related services.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly PE-Backed
Corporate Office
  • 35/F, Enterprise Square Two, Number. 3 Sheung Yuet Road
  • Kowloon Bay
  • Hong Kong
  • Hong Kong
Primary Industry
Diagnostic Equipment
Other Industries
Monitoring Equipment
Stock Exchange
SHE
Corporate Office
  • 35/F, Enterprise Square Two, Number. 3 Sheung Yuet Road
  • Kowloon Bay
  • Hong Kong
  • Hong Kong

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Guangdong Hybribio Biotech Company Stock Performance

As of 13-Nov-2026, Guangdong Hybribio Biotech Company’s stock price is $0.82. Its current market cap is $529M with 647M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.82 $0.85 $0.70 - $1.45 $529M 647M 14.7M $0.01

Guangdong Hybribio Biotech Company Financials Summary

As of 30-Sep-2026, Guangdong Hybribio Biotech Company has a trailing 12-month revenue of $93.1M.

In Thousands,
USD
TTM 30-Sep-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 478,226 362,090 426,791 758,155
Revenue 93,093 93,118 113,655 156,109
EBITDA 11,990 (3,494) (95,307) 26,388
Net Income 9,672 (18,208) (91,267) 19,855
Total Assets 622,518 592,803 633,277 807,746
Total Debt 26,539 12,801 11,988 7,992
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Guangdong Hybribio Biotech Company Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Guangdong Hybribio Biotech Company‘s full profile, request access.

Request a free trial

Guangdong Hybribio Biotech Company Patents

Guangdong Hybribio Biotech Company Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-2025524260-A A microfluidic chip for sorting live cells Active 13-Jun-2023
JP-7760736-B2 A microfluidic chip for sorting live cells Active 13-Jun-2023
EP-4497811-A1 Micro-fluidic chip for sorting living cells Active 13-Jun-2023
EP-4497811-A4 Micro-fluidic chip for sorting living cells Active 13-Jun-2023
EP-4497811-B1 Micro-fluidic chip for sorting living cells Active 13-Jun-2023 B01L3/502746
To view Guangdong Hybribio Biotech Company’s complete patent history, request access »

Guangdong Hybribio Biotech Company Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Guangdong Hybribio Biotech Company Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Guangdong Hybribio Biotech Company‘s full profile, request access.

Request a free trial

Guangdong Hybribio Biotech Company Investments (7)

Guangdong Hybribio Biotech Company’s most recent deal was a Later Stage VC with Salus BioMed. The deal was made on 10-Sep-2026.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Salus BioMed 10-Sep-2026 Later Stage VC Diagnostic Equipment
MirrorEgo 24-Mar-2026 Later Stage VC Decision/Risk Analysis
Gaugene 01-Jul-2022 Later Stage VC Diagnostic Equipment
Ammunition Life Technology 02-Feb-2021 Later Stage VC Diagnostic Equipment
Uzer Technology 12-Jan-2021 Corporate Diagnostic Equipment
You’re viewing 5 of 7 investments. Get the full list »

Guangdong Hybribio Biotech Company ESG

Risk Overview

Risk Rating

Updated December, 31, 2023

27.66 | Med Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 15,201

Rank

Percentile

Pharmaceuticals

Industry

of 863

Rank

Percentile

Biotechnology

Subindustry

of 373

Rank

Percentile

To view Guangdong Hybribio Biotech Company’s complete esg history, request access »

Guangdong Hybribio Biotech Company FAQs

  • When was Guangdong Hybribio Biotech Company founded?

    Guangdong Hybribio Biotech Company was founded in 2003.

  • Where is Guangdong Hybribio Biotech Company headquartered?

    Guangdong Hybribio Biotech Company is headquartered in Hong Kong, Hong Kong.

  • What is the size of Guangdong Hybribio Biotech Company?

    Guangdong Hybribio Biotech Company has 1,990 total employees.

  • What industry is Guangdong Hybribio Biotech Company in?

    Guangdong Hybribio Biotech Company’s primary industry is Diagnostic Equipment.

  • Is Guangdong Hybribio Biotech Company a private or public company?

    Guangdong Hybribio Biotech Company is a Public company.

  • What is Guangdong Hybribio Biotech Company’s stock symbol?

    The ticker symbol for Guangdong Hybribio Biotech Company is 300639.

  • What is the current stock price of Guangdong Hybribio Biotech Company?

    As of 13-Nov-2026 the stock price of Guangdong Hybribio Biotech Company is $0.82.

  • What is the current market cap of Guangdong Hybribio Biotech Company?

    The current market capitalization of Guangdong Hybribio Biotech Company is $529M.

  • What is Guangdong Hybribio Biotech Company’s current revenue?

    The trailing twelve month revenue for Guangdong Hybribio Biotech Company is $93.1M.

  • What is Guangdong Hybribio Biotech Company’s annual earnings per share (EPS)?

    Guangdong Hybribio Biotech Company’s EPS for 12 months was $0.01.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process